"I am excited by a new collaboration with Amarant
Post# of 30028
Posted On: 11/30/2014 8:16:49 AM
Quote:
"I am excited by a new collaboration with Amarantus Bioscience to develop a revolutionary therapy for Wolfram syndrome, the most difficult form of blindness and diabetes. We plan to use MANF protein to achieve this goal. Amarantus is a leading biotech company developing MANF-based therapies for neurodegeneration and blindness, and my team has expertise in Wolfram syndrome making for a wonderful collaboration."
-Fumihiko Urano
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼